In contrast, IDH-mutant GBMs are defined as secondary GBMs and are currently included in astrocytoma WHO CNS grade 4 (Ohgaki and Kleihues, 2013; Louis et al., 2016). Here, IDH1 is linked to astrocytoma (excluding glioblastoma).